Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,465 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | completed | Phase 1 | 8 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00881946 | Repeat Dose Safety Study for Compound to Treat Hematologic Cancer | completed | Phase 1 / Phase 2 | 73 | AccentureINDUSTRY | 3 | Apr 4, 2012 | clinicaltrials |
| NCT01089049 |
| Effect of a Natural Health Product on Urinary Estrogen Metabolites |
| completed |
| Phase 1 / Phase 2 |
| 98 |
| Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK |
| 1 |
| Mar 26, 2012 |
| clinicaltrials |
| NCT00022451 | Tipifarnib in Treating Young Patients With Refractory Leukemia | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 3 | Mar 15, 2012 | clinicaltrials |
| NCT00569712 | Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol | completed | Phase 1 | 30 | British Columbia Cancer AgencyOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00959868 | A Study for Treatment of Superficial Bladder Cancer Using OGX-427 | unknown | Phase 1 | 36 | Vancouver Coastal HealthOTHER_GOV | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00125684 | Bioavailability and Effectiveness of Transdermally Administered Morphine | completed | Phase 1 | 6 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00168129 | Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases | completed | Phase 1 | 10 | Alberta Health servicesOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01476878 | Frameless Stereotactic Radiosurgery for Brain Metastases | unknown | Phase 1 / Phase 2 | 20 | Alberta Health servicesOTHER | 1 | Nov 22, 2011 | clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00916877 | Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer | completed | Phase 1 | 110 | Alberta Health servicesOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00904787 | Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies | completed | Phase 1 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00768339 | A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas | terminated | Phase 1 / Phase 2 | 25 | Aegera TherapeuticsINDUSTRY | 2 | Jul 13, 2011 | clinicaltrials |
| NCT00369447 | A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 52 | YM BioSciencesINDUSTRY | 3 | Jul 1, 2011 | clinicaltrials |
| NCT00809796 | A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment | completed | Phase 1 / Phase 2 | 15 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00810953 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | completed | Phase 1 / Phase 2 | 10 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 86 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 16, 2011 | clinicaltrials |
| NCT00805883 | MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy | completed | Phase 1 | 10 | University Health Network, TorontoOTHER | 1 | May 27, 2011 | clinicaltrials |
| NCT00750425 | Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours | completed | Phase 1 | 46 | AstraZenecaINDUSTRY | 2 | Mar 10, 2011 | clinicaltrials |
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT00329004 | A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 89 | Bristol-Myers SquibbINDUSTRY | 4 | Jan 25, 2011 | clinicaltrials |
| NCT00460460 | Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies | terminated | Phase 1 | 75 | AstraZenecaINDUSTRY | 2 | Jan 25, 2011 | clinicaltrials |
| NCT00354562 | A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 75 | AbbottINDUSTRY | 4 | Jan 7, 2011 | clinicaltrials |
| NCT00276302 | Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) | completed | Phase 1 | 63 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 6, 2011 | clinicaltrials |
| NCT00486265 | Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) | terminated | Phase 1 | 47 | AstraZenecaINDUSTRY | 2 | Dec 21, 2010 | clinicaltrials |
| NCT00188656 | Computed Tomography (CT) in Head and Neck Patients | terminated | Phase 1 | 100 | University Health Network, TorontoOTHER | 1 | Dec 15, 2010 | clinicaltrials |
| NCT00417885 | A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer | terminated | Phase 1 / Phase 2 | 6 | PfizerINDUSTRY | 2 | Sep 21, 2010 | clinicaltrials |
| NCT00188565 | Celebrex With Preoperative Chemoradiation - Rectal Cancer | completed | Phase 1 / Phase 2 | 39 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT00232440 | Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma | completed | Phase 1 / Phase 2 | 20 | University Health Network, TorontoOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00252447 | Preop Conformal Radiotherapy - Prostate | completed | Phase 1 / Phase 2 | 15 | University Health Network, TorontoOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00003073 | Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors | unknown | Phase 1 | 15 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Mar 23, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00129051 | Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases | completed | Phase 1 | 20 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00061997 | Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers | completed | Phase 1 | — | British Columbia Cancer AgencyOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00363974 | Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML | completed | Phase 1 / Phase 2 | 54 | Aegera TherapeuticsINDUSTRY | 2 | Dec 1, 2009 | clinicaltrials |
| NCT01022333 | The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT00351325 | A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies | terminated | Phase 1 | 45 | Bristol-Myers SquibbINDUSTRY | 2 | Sep 4, 2009 | clinicaltrials |
| NCT00573820 | Far Infrared Radiation Treatment for Prostate Cancer | unknown | Phase 1 | 4 | GAAD Medical Research Institute Inc.OTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00574106 | A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment | unknown | Phase 1 | 3 | GAAD Medical Research Institute Inc.OTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00230386 | Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma | completed | Phase 1 / Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00506402 | A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies | completed | Phase 1 | 30 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | May 5, 2009 | clinicaltrials |
| NCT00070083 | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | completed | Phase 1 | — | British Columbia Cancer AgencyOTHER | 2 | Apr 7, 2009 | clinicaltrials |
| NCT00573573 | Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism | unknown | Phase 1 | 2 | GAAD Medical Research Institute Inc.OTHER | 1 | Mar 24, 2009 | clinicaltrials |
| NCT00574418 | Far Infrared Radiation Treatment for Uterine Fibroids | unknown | Phase 1 | 2 | GAAD Medical Research Institute Inc.OTHER | 1 | Jan 5, 2009 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials